View highlights and coverage from leading international Neurology congresses
We had the great pleasure of meeting with Stephanie Nahas (Thomas Jefferson University, Jefferson Headache Center, Philadelphia, PA, USA) to discuss the HALO long term extension study investigating long term efficacy and tolerability of fremanezumab in patients with episodic and chronic migraine. The abstract ‘Clinically Meaningful Responses to Fremanezumab Treatment in Episodic and Chronic Migraine […]
We had the great pleasure of meeting with Stephanie Nahas (Thomas Jefferson University, Jefferson Headache Center, Philadelphia, PA, USA) to discuss the CaMEO results, a web-based survey to characterize self-reported use of preventive medications for migraine and treatment gaps. The abstract ‘Characterizing preventive treatment gaps in migraine: Results from the CaMEO study’ & ‘Optimal acute […]
touchNEUROLOGY met with Robert Shapiro (Larner College of Medicine at the University of Vermont, Burlington, VT, USA) to discuss the impact of COVID-19 on individuals with migraine. The abstract ‘Migraine Is Associated With Higher Incidence of COVID-19, and Higher Frequency of COVID-19 Symptoms, but Lower COVID-19-Associated Health Care Resource Utilization Rates’ was presented at the […]
It was a great pleasure to meet with Amy Gelfand (University of California, San Francisco, CA, USA) to discuss some of the highlights from this years AHS Meeting. Question: What are some of the highlights from this year’s AHS Annual Meeting? Useful resources: WOLFF Award Winner: Ryotaro Ishii et al., Headache. Chronic versus episodic migraine: […]
touchNEUROLOGY had the pleasure of meeting with Amy Gelfand (University of California, San Francisco, CA, USA) to discuss what is known about the impact of preventative migraine medication on the COVID-19 vaccine. The session ‘Vaccines and Their Impact on Migraine Treatment’ was presented at the American Headache Society (AHS) Virtual Annual Scientific Meeting 2021, 3-6 […]
It was a great pleasure to meet with Richard Lipton (Albert Einstein College of Medicine, Bronx, NY, USA) to discuss the impact in the use of CGRP antagonists in migraine therapy. The abstract ‘Combining UbRogepAnt and Preventives for MiGrainE (COURAGE) Study Using the Migraine Buddy Application: A Novel, Entirely Remote Design for Collecting Real-world Evidence’ […]
touchNEUROLOGY met with Richard Lipton (Albert Einstein College of Medicine, Bronx, NY, USA) to discuss the COURAGE study results investigating the Migraine Buddy Application. The abstract ‘Combining UbRogepAnt and Preventives for MiGrainE (COURAGE) Study Using the Migraine Buddy Application: A Novel, Entirely Remote Design for Collecting Real-world Evidence’ was presented at the American Headache Society […]
It was a great pleasure to meet with Jessica Ailani (AHS Scientific Committee Member) (MedStar Georgetown Headache Center, Georgetown, WA, USA) to discuss the RELIEF study results. The abstract ‘Rapid Resolution of Migraine Symptoms After Initiating the Preventive Treatment Eptinezumab During a Migraine Attack’ was presented at the American Headache Society (AHS) Virtual Annual Scientific […]
Get the latest clinical insights from touchNEUROLOGY
